ES
12
3
HRB
40
3
BDX
59
3
MDLZ
28
2
GME
61
2
SPG
45
2
BK
60
2
CHD
34
7
CNP
59
17
CF
47
5
LEG
16
2
UNH
42
6
WHR
61
3
HBAN
47
7
DD
44
2
DUK
49
4
AFL
34
6
DTE
49
16
THC
52
9
CRM
65
6
ES
12
3
HRB
40
3
BDX
59
3
MDLZ
28
2
GME
61
2
SPG
45
2
BK
60
2
CHD
34
7
CNP
59
17
CF
47
5
LEG
16
2
UNH
42
6
WHR
61
3
HBAN
47
7
DD
44
2
DUK
49
4
AFL
34
6
DTE
49
16
THC
52
9
CRM
65
6
Financhill
Back

IGM Biosciences 10K Form

Sell
14

IGMS
IGM Biosciences

Last Price:
$6.94
Seasonality Move:
3.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IGMS News And Ratings

See the #1 stock for the next 7 days that we like better than IGMS

IGMS Financial Statistics

Sales & Book Value

Annual Sales: $2.1M
Cash Flow: $-39.7M
Price / Cash Flow: 0
Annual Sales: $1.33
Price / Book: 5.2

Profitability

EPS (TTM): -3.61000
Net Income (TTM): $-219.8M
Gross Margin: --
Return on Equity: -134.11%
Return on Assets: -57.4%

IGM Biosciences Earnings Forecast

Key IGM Biosciences Financial Ratios

  • The Research & Development expenses have been 10,118.26% of Revenue.
  • The Net Earning history of IGMS is -11,568.83% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

IGM Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IGMS
CUSIP: 449585
Website: igmbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.22
Quick Ratio: 4.98

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IGMS Technical Analysis vs Fundamental Analysis

Sell
14
IGM Biosciences (IGMS) is a Sell

Is IGM Biosciences a Buy or a Sell?

  • IGM Biosciences stock is rated a Sell
    The current IGM Biosciences [IGMS] share price is $6.90. The Score for IGMS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.